Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

Pediatric Transplants

Abnormal liver enzymes 2 years after haematopoietic stem cell transplantation in children: prevalence and risk factors

Bone Marrow Transplantation volume 41, pages 27–31 (2008)Cite this article

Abstract

To establish the prevalence of elevated liver enzymes in children transplanted in a Dutch haematopoietic stem cell transplantation (HSCT) centre, we retrospectively assessed AST and ALT values at 2 years after HSCT. Age, sex, diagnosis, type of transplant, conditioning regimen and early post-transplant complications involving the liver (veno-occlusive disease, acute GVHD, viral reactivation) were analysed as risk factors. AST and ALT values were available at 2 years after HSCT in 216 of 290 patients (75%) alive at that time and were above normal in 53 (25%) and at least twice normal in 17 (8%) patients. Older age at HSCT and a diagnosis of benign haematological disease are risk factors for abnormal liver enzymes late after HSCT. In half of the patients with benign haematological disease, iron overload is the most likely aetiological factor. Chronic hepatitis B or C is uncommon in our centre. In conclusion, the prevalence of abnormal liver enzymes late after HSCT in our centre is lower than reported in previous studies. Abnormal liver enzymes occur more often in children who are older at HSCT and transplanted for benign haematological disease. Long-term follow-up is crucial to establish if elevated liver enzymes precede clinical liver disease.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Similar content being viewed by others

References

  1. Kim BK, Chung KW, Sun HS, Suh JG, Min WS, Kang CS et al. Liver disease during the first post-transplant year in bone marrow transplantation recipients: retrospective study. Bone Marrow Transplant 2000; 26: 193–197.

    Article  CAS  PubMed  Google Scholar 

  2. Özdoğan O, Ratip S, Al Ahdab Y, Dane F, Al Ahdab H, Imeryüz N et al. Causes and risk factors for liver injury following bone marrow transplantation. J Clin Gastroenterol 2003; 36: 421–426.

    Article  PubMed  Google Scholar 

  3. Ho GT, Parker A, MacKenzie JF, Morris AJ, Stanley AJ . Abnormal liver function tests following bone marrow transplantation: aetiology and role of liver biopsy. Eur J Gastroenterol Hepatol 2004; 16: 157–162.

    Article  PubMed  Google Scholar 

  4. Azar N, Valla D, Abdel-Samad I, Hoang C, Fretz C, Sutton L et al. Liver dysfunction in allogeneic bone marrow transplantation recipients. Transplantation 1996; 62: 56–61.

    Article  CAS  PubMed  Google Scholar 

  5. Locasciulli A, Testa M, Valsecchi MG, Bacigalupo A, Solinas S, Tomas JF et al. The role of hepatitis C and B virus infections as risk factors for severe liver complications following allogeneic BMT: a prospective study by the infectious disease working party of the European Blood and Marrow Transplantation Group. Transplantation 1999; 68: 1486–1491.

    Article  CAS  PubMed  Google Scholar 

  6. Barker CC, Anderson RA, Sauve RS, Butzner JD . GI complications in pediatric patients post-BMT. Bone Marrow Transplant 2005; 36: 51–58.

    Article  CAS  PubMed  Google Scholar 

  7. Harrison P, Neilson JR, Marwah SS, Madden L, Bareford D, Milligan DW . Role of non-transferring bound iron in iron overload and liver dysfunction in long term survivors of acute leukaemia and bone marrow transplantation. J Clin Pathol 1996; 49: 853–856.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  8. Strasser SI, Sullivan KM, Myerson D, Spurgeon CL, Storer B, Schoch HG et al. Cirrhosis of the liver in long-term marrow transplant survivors. Blood 1999; 93: 3259–3266.

    CAS  PubMed  Google Scholar 

  9. Locasciulli A, Testa M, Valsecchi MG, Vecchi L, Longoni D, Sparano P et al. Morbidity and mortality due to liver disease in children undergoing allogeneic bone marrow transplantation: a 10-year prospective study. Blood 1997; 90: 3799–3805.

    CAS  PubMed  Google Scholar 

  10. Tomás JF, Pinilla I, García-Buey ML, García A, Figuera A, Gómez-García de Soria V et al. Long-term liver dysfunction after allogeneic bone marrow transplantation: clinical features and course in 61 patients. Bone Marrow Transplant 2000; 26: 649–655.

    Article  PubMed  Google Scholar 

  11. Frisk P, Lönnerholm G, Öberg G . Disease of the liver following bone marrow transplantation in children: incidence, clinical course and outcome in a long-term perspective. Acta Paediatr 1998; 87: 579–583.

    Article  CAS  PubMed  Google Scholar 

  12. Strasser SI, Kowdley KV, Sale GE, McDonald GB . Iron overload in bone marrow transplant recipients. Bone Marrow Transplant 1998; 22: 167–173.

    Article  CAS  PubMed  Google Scholar 

  13. McKay PJ, Murphy JA, Cameron S, Burnett AK, Campbell M, Tansey P et al. Iron overload and liver dysfunction after allogeneic or autologous bone marrow transplantation. Bone Marrow Transplant 1996; 17: 63–66.

    CAS  PubMed  Google Scholar 

  14. Ivantes CAP, Amarante H, Ioshii SO, Pasquini R . Hepatitis C virus in long-term bone marrow transplant survivors. Bone Marrow Transplant 2004; 33: 1181–1185.

    Article  CAS  PubMed  Google Scholar 

  15. Van der Poel CL, Reesink HW, Mauser-Bunschoten EP, Kaufmann RH, Leentvaar-Kuypers A, Chamuleau RA et al. Prevalence of anti-HCV antibodies confirmed by recombinant immunoblot in different population subsets in the Netherlands. Vox Sanguin 1991; 61: 30–36.

    Article  CAS  Google Scholar 

  16. Jones RJ, Lee KS, Beschorner WE, Vogel VG, Grochow LB, Braine HG et al. Veno occlusive disease of the liver following bone marrow transplantation. Transplantation 1987; 44: 778–783.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Paediatric Immunology, Haemato-Oncology, Bone Marrow Transplantation and Auto-immune Diseases, Leiden University Medical Centre, Leiden, The Netherlands

    D Bresters, I C M Van Gils, A C Lankester & R G M Bredius

  2. Department of Clinical Epidemiology, Leiden University Medical Centre, Leiden, The Netherlands

    F W Dekker

  3. Unit for Paediatric Gastroenterology and Nutrition, Leiden University Medical Centre, Leiden, The Netherlands

    J J Schweizer

Authors
  1. D Bresters
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. I C M Van Gils
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. F W Dekker
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. A C Lankester
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. R G M Bredius
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. J J Schweizer
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to D Bresters.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Bresters, D., Van Gils, I., Dekker, F. et al. Abnormal liver enzymes 2 years after haematopoietic stem cell transplantation in children: prevalence and risk factors. Bone Marrow Transplant 41, 27–31 (2008). https://doi.org/10.1038/sj.bmt.1705887

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.bmt.1705887

Keywords

Search

Advanced search

Quick links